𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen replacement therapy and ovarian cancer risk

✍ Scribed by Fabio Parazzini; Carlo La Vecchia; Eva Negri; Antonella Villa


Publisher
John Wiley and Sons
Year
1994
Tongue
French
Weight
144 KB
Volume
57
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Use of hormone replacement therapy befor
✍ Chantal Mascarenhas; Mats Lambe; Rino Bellocco; Kjell Bergfeldt; Tomas Riman; In πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 190 KB

## Abstract Use of hormone replacement therapy (HRT) has been hypothesized to affect survival of epithelial ovarian cancer (EOC). We studied 5‐year survival in patients with invasive EOC and borderline ovarian tumors (BOT) according to HRT use before and after diagnosis in a prospective nation‐wide

Estrogen replacement therapy for ovarian
✍ Franco Guidozzi; Alexandros Daponte πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views

## BACKGROUND. Surgery for premenopausal and perimenopausal patients with epithelial ovarian carcinoma may often result in significant menopausal symptoms. Physicians may well be reluctant to prescribe, and patients loathe to take, postoperative estrogen replacement therapy because they fear that

Hormone replacement therapy and lung can
✍ Kuan-Yu Chen; Chin-Fu Hsiao; Gee-Chen Chang; Yin-Huang Tsai; Wu-Chou Su; Reury-P πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The association between hormone replacement therapy (HRT) and a reduced lung cancer risk has been reported in previous studies. There is a high female to male ratio in Chinese lung cancer patients, and female patients have different clinicopathological characteristics co